Searched for
ZIFY
Vinay Jaising on why NBFCs and housing finance stocks are gaining ground?Our growth is already there and we have also seen the debt market linked up globally with us, including in the global EMI index. So, you ar...- This time tailwinds for good and long term: 5 midcap pharma stocks where probably management has learnt the lessonPharma is one sector, where literally every company in the sector has gone through a phase where it is forced to have a look at its own bus...
- Anti-diabetic drugs lead growth in pharmaceuticals marketThe pharmaceuticals market in India is witnessing significant growth, with anti-diabetic drugs leading the way with over ₹155 crore in valu...
- On a path to recovery; 7 mid-cap pharma stocks with an upside potential up to 47 %After the covid tailwinds got over, pharma stocks witnessed a phase of under-performance. However as the markets get jittery, select pharma...
- Defensive Bets: 4 midcaps from pharma sector with ‘Buy’ & ‘Strong Buy’ ratings have upside potential of up to 31%As NIFTY gets even more volatile, there are some sectors which are traditionally considered defensive and they tend to get attention when m...
- Mumbai pharma co may raise Rs 1200 cr by selling minority stakeMultiple people aware of the development told ET that the major brands to be brought under the new entity include the market leading ORS br...
- Buy FDC, target price Rs 360: Anand RathiFDC Ltd. was founded in 1936 to import drugs, infant foods and surgical appliances for distribution in India.
- Add FDC, target Rs 180: Centrum BrokingFDC is a smallcap company, operating in pharmaceuticals and health care sector.
- Better than Jio? This startup can end your Internet speed woesZifiLink works as a portable WiFi router that converges eight different telecom networks to provide one ultra-fast internet connection.
- Play time: SuperSuit to bring back outdoor games with its wearable gaming platformChildren can put on the suit and choose a game through an LCD display on the glove to start playing it.
- Reliance eyes Rs 1,800 cr sales from Vimal brand in 3 yearsReliance Industries Ltd is looking at over 2-fold increase in sales to Rs 1,800 crore from its textiles brand Vimal in the next three years...
- Smart city hackathon at Sikkim, the first of its kind in north east"We had a phenomenal response and some great innovations, and we plan to connect these innovators to the incubators that we are partnered w...
- FDC promoters plan to sell 67% stake; stock hits 52-week highFDC surged over 14% to hit a 52-week high of Rs 105.95 on reports that the promoters of the pharma firm, plan to sell their 67% stake in th...
- FDC owners in talks to exit; plan to sell their 67% stakeBuyout fund Carlyle had shown interest in buying the company and had even valued it at about Rs 3,800 crore.
- Pharma growth slows down to 9.6%Growth in the domestic pharma market dipped in September over the previous month, but was still nearly double digit at 9.6%.
Load More
